Key Factors Fueling the Growth of the Predictive And Presymptomatic Testing Market in 2025: Rising Prevalence Of Genetic Disorders Fuels Growth In Predictive And Presymptomatic Testing Market
Discover trends, market shifts, and competitive outlooks for the predictive and presymptomatic testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Predictive And Presymptomatic Testing Market Size from 2025 to 2034?
Rapid expansion has been seen in the predictive and presymptomatic testing market over the recent years. Its size is predicted to increase from $5.24 billion in 2024 to $5.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.3%. Several factors contributed to this growth during the historical period. These include the growing cases of genetic disorders, heightened demand for early detection of chronic illnesses, increased prevalence of cancer, a trend towards personalized medicine, and wider accessibility of direct-to-consumer genetic tests.
Within the coming years, a swift expansion is anticipated in the predictive and presymptomatic testing market. The projection indicates that this sector will elevate to $8.47 billion by 2029, witnessing a compound annual growth rate (CAGR) of 10.1%. This surge during the forecast period can be owed to increased interest in early disease detection, amplified investments in biotechnology and genomics, a growing preference for non-invasive testing strategies, an aging population, and advancements in precision medicine initiatives. Key trends expected to emerge during this period include the embrace of personalized medicine, the usage of home testing kits, the merger of genomics and big data, the formation of next-generation sequencing (NGS) technologies, and the application of predictive testing in the domain of drug development.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20594&type=smp
What are the Fundamental Drivers and Innovations Shaping the Predictive And Presymptomatic Testing Market?
The upward trend of genetic disorders is anticipated to boost the growth of the predictive and presymptomatic testing market in the future. Genetic disorders are illnesses stemming from abnormalities in deoxyribonucleic acid (DNA) like gene mutations and chromosome alterations, exemplified by conditions such as cystic fibrosis and down syndrome. The heightened prevalence is due to contributing factors like advanced maternal age, environmental influences, and improved diagnostic techniques. Predictive and presymptomatic testing is pivotal in curtailing the incidence of genetic disorders by identifying at-risk individuals before symptoms appear. Such a preventive strategy enables early interventions or lifestyle modifications, which can stave off or reduce the severity of these conditions. For example, the American Society of Gene and Cell Therapy, a US-based non-profit medical and scientific association, reported in June 2023 that there was a 10% growth in gene therapies in Phase III clinical trials in Q3 2023, marking the first quarterly increase since Q3 2022. Hence, the escalating occurrence of genetic disorders is fuelling the predictive and presymptomatic testing market.
How Is the Predictive And Presymptomatic Testing Market Segmented?
The predictive and presymptomatic testing market covered in this report is segmented –
1) By Test Type: Predictive Testing, Presymptomatic Testing
2) By Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Other Applications
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Predictive Testing: Genetic Testing for Inherited Conditions, Cancer Risk Prediction, Cardiovascular Disease Prediction, Neurodegenerative Disease Risk Prediction, Genetic Screening for Autosomal Dominant Disorders, Prenatal Predictive Testing, Pharmacogenomic Testing
2) By Presymptomatic Testing: Huntington’s Disease Testing, Hereditary Cancer Risk Testing, Cystic Fibrosis Presymptomatic Testing, Early-Onset Alzheimer’s Disease Testing, Carrier Screening for Genetic Conditions, Testing for Early Signs of Neurodegenerative Diseases, Presymptomatic Genetic Testing for Familial Diseases
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20594&type=smp
Which Regions Are Driving the Next Phase of the Predictive And Presymptomatic Testing Market Growth?
North America was the largest region in the predictive and presymptomatic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive and presymptomatic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Predictive And Presymptomatic Testing Market?
Leading firms in the predictive and presymptomatic testing market are advancing their services by creating innovative examinations such as multigene testing. This approach evaluates numerous genes simultaneously to detect potential health issues and allow for early interventions. Multigene testing is a healthcare diagnostic method that scrutinizes multiple genes at once to spot genetic mutations or variations that could be linked to certain diseases or conditions, assisting in personalized medicine and specific treatment plans. For example, Genetic Technologies Limited, a biotechnology research company based in Australia, collaborated with Siles Health, a women’s healthcare center from the same country, in July 2022. They introduced the geneType Multi-Risk Test, designed to offer wide-ranging risk evaluations for patients. This test, an exhaustive genetic examination tool, gauges a patient’s risk for several critical diseases, such as breast cancer, colorectal cancer, and type 2 diabetes. The test seeks to facilitate personalized healthcare planning and early interventions by studying both hereditary and sporadic genetic factors.
View the full report here:
How Is the Predictive And Presymptomatic Testing Market Defined and What Are Its Core Parameters?
Predictive and presymptomatic testing are genetic tests designed to assess an individual’s risk of developing a disease before any symptoms arise, particularly for inherited conditions. These tests help identify people at increased risk for specific genetic disorders, enabling early intervention and personalized care. The benefits include early diagnosis, tailored prevention, and informed lifestyle choices.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20594
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
